FDA notifications.  FDA approval for generic lamivudine/zidovudine.
D017277:Drug Approval / Q000331:legislation & jurisprudence*; D016568:Drugs, Generic; D015658:HIV Infections / Q000188:drug therapy; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use*; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration; D015215:Zidovudine / Q000627:therapeutic use*
D016568:Drugs, Generic; D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine; D015215:Zidovudine